Open Label Randomized Single Study to Evaluate the Safety & Efficacy of Early CNI Withdrawal in Recipients of Primary Renal Allografts Maintained Long-Term on Mycophenolate Mofetil; MMF (CellCept) and Sirolimus (Rapamune)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Mycophenolate mofetil; Sirolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 15 Jul 2021 Biomarkers information updated
- 05 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2006 New trial record.